Medications for Polycythemia Vera

3 results

  • Besremi

    (ropeginterferon alfa-2b)
    Pharmaessentia Usa Corporation
    Usage: BESREMi is indicated for the treatment of adults with polycythemia vera.

  • Jakafi

    (ruxolitinib)
    Incyte Corporation
    Usage: Jakafi is indicated for the treatment of intermediate or high-risk myelofibrosis, polycythemia vera in adults intolerant to hydroxyurea, steroid-refractory acute graft-versus-host disease in patients aged 12 and older, and chronic graft-versus-host disease after failure of one or two systemic therapies in the same age group.

  • P32 sodium phosphate (p32 sodium phosphate)

    (P32 Sodium Phosphate)
    AnazaoHealth Corporation
    Usage: P32 sodium phosphate is indicated for treating polycythemia vera and is effective in chronic myelocytic and chronic lymphocytic leukemia. It may also be used palliatively in selected patients with multiple skeletal metastases.